Modeling Cancer with Pluripotent Stem Cells

被引：28

作者：

Gingold, Julian ^{[1
]}

Zhou, Ruoji ^{[2
,3
]}

Lemischka, Ihor R. ^{[4
,5
,6
]}

Lee, Dung-Fang ^{[2
,3
,7
]}

机构：

[1] Cleveland Clin Fdn, Womens Hlth Inst, Cleveland, OH 44195 USA

[2] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA

[3] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA

[4] Icahn Sch Med Mt Sinai, Dept Dev & Regenerat Biol, New York, NY 10029 USA

[5] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA

[6] Icahn Sch Med Mt, Black Family Stem Cell Inst, New York, NY 10029 USA

[7] Univ Texas Hlth Sci Ctr Houston, Ctr Stem Cell & Regenerat Med, Brown Fdn, Inst Mol Med Prevent Human Dis, Houston, TX 77030 USA

来源：

TRENDS IN CANCER | 2016年 / 2卷 / 09期

关键词：

TARGETED GENE CORRECTION; FUNCTIONAL HUMAN LIVER; KIDNEY ORGANOIDS; HUMAN ES; DIRECTED DIFFERENTIATION; PROGENITOR CELLS; SELF-RENEWAL; IPS CELLS; GENERATION; DISEASE;

D O I：

10.1016/j.trecan.2016.07.007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The elucidation of cancer pathogenesis has been hindered by limited access to patient samples, tumor heterogeneity, and the lack of reliable model organisms. Characterized by their ability to self-renew indefinitely and differentiate into all adult cell lineages of an organism, pluripotent stem cells (PSCs), including ESCs and induced pluripotent stem cells (iPSCs), provide a powerful and unlimited source to generate differentiated cells that can be used to study disease biology, facilitate drug discovery and development, and provide key insights for developing personalized therapies. This article reviews the recent developments and technologies converting PSCs into clinically relevant model systems for cancer research.

引用

页码：485 / 494

页数：10

共 50 条

[21] Modeling Leukemia with Human Induced Pluripotent Stem Cells
Papapetrou, Eirini P.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2019, 9 (12):
[22] Probabilistic Modeling of Reprogramming to Induced Pluripotent Stem Cells
Liu, Lin L.
Brumbaugh, Justin
Bar-Nur, Ori
Smith, Zachary
Stadtfeld, Matthias
Meissner, Alexander
Hochedlinger, Konrad
Michor, Franziska
CELL REPORTS, 2016, 17 (12): : 3395 - 3406
[23] Cancer Stem Cells Converted from Pluripotent Stem Cells and the Cancerous Niche
Kasai, T.
Chen, L.
Mizutani, A.
Kudoh, T.
Murakami, H.
Fu, L.
Seno, M.
JOURNAL OF STEM CELLS & REGENERATIVE MEDICINE, 2014, 10 (01): : P2 - P7
[24] Cancer cells as a new source of induced pluripotent stem cells
Shamsian, Azam
Sahebnasagh, Roxana
Norouzy, Amir
Hussein, Safin Hassan
Ghahremani, Mohammad Hossein
Azizi, Zahra
STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
[25] Cancer cells as a new source of induced pluripotent stem cells
Azam Shamsian
Roxana Sahebnasagh
Amir Norouzy
Safin Hassan Hussein
Mohammad Hossein Ghahremani
Zahra Azizi
Stem Cell Research & Therapy, 13
[26] Reprogramming of Cancer Cells into Induced Pluripotent Stem Cells Questioned
Bang, Jin Seok
Choi, Na Young
Lee, Minseong
Ko, Kisung
Park, Yo Seph
Ko, Kinarm
INTERNATIONAL JOURNAL OF STEM CELLS, 2019, 12 (03) : 430 - 439
[27] Modeling cancer progression using human pluripotent stem cell-derived cells and organoids
Zhang, Meili
Vandana, J. Jeya
Lacko, Lauretta
Chen, Shuibing
STEM CELL RESEARCH, 2020, 49
[28] Modeling of limbal stem cell differentiation using human pluripotent stem cells
Skottman, Heli
Vattulainen, Meri Hilja Maria
Viiri, Keijo
Ilmarinen, Tanja
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
[29] Chromatin structure of pluripotent stem cells and induced pluripotent stem cells
Delgado-Olguin, Paul
Recillas-Targa, Felix
BRIEFINGS IN FUNCTIONAL GENOMICS, 2011, 10 (01) : 37 - 49
[30] Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells
Naphade, Swati
Tshilenge, Kizito-Tshitoko
Ellerby, Lisa M.
NEUROTHERAPEUTICS, 2019, 16 (04) : 979 - 998

← 1 2 3 4 5 →